Answers are grounded in this paper and cite their sources.
Survey assesses JAK inhibitors' use in alopecia areata among dermatologists, highlighting treatment challenges.
Despite a European expert consensus statement on the systemic treatment of alopecia areata, the absence of global guidelines and limited information on the long-term safety of JAKi use still poses challenges to clinicians. A cross-sectional survey was conducted to assess the use of JAKi in AA among consultant dermatologists in Ireland.
No takes yet. Share an insight, caveat, or question.
Grechin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: